Literature DB >> 18980177

Guggulsterone: a potent farnesoid X receptor antagonist and its rapidly evolving role as a systemic anticarcinogenic agent.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980177     DOI: 10.1002/hep.22601

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.

Authors:  Muzafar A Macha; Satyanarayana Rachagani; Suprit Gupta; Priya Pai; Moorthy P Ponnusamy; Surinder K Batra; Maneesh Jain
Journal:  Cancer Lett       Date:  2013-08-03       Impact factor: 8.679

2.  14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells.

Authors:  Muzafar A Macha; Ajay Matta; Ss Chauhan; Kw Michael Siu; Ranju Ralhan
Journal:  BMC Cancer       Date:  2010-11-30       Impact factor: 4.430

Review 3.  Potential therapeutic targets of Guggulsterone in cancer.

Authors:  Ajaz A Bhat; Kirti S Prabhu; Shilpa Kuttikrishnan; Roopesh Krishnankutty; Jayaprakash Babu; Ramzi M Mohammad; Shahab Uddin
Journal:  Nutr Metab (Lond)       Date:  2017-02-28       Impact factor: 4.169

4.  Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.

Authors:  Zhongsheng Peng; Jean-Pierre Raufman; Guofeng Xie
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.